If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Mancuso, Patrizia ^a   Calleri, Angelica ^a   Antoniotti, Pierluigi ^a   Quarna, Jessica ^a   Pruneri, Giancarlo ^a   Bertolini, Francesco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; RITUXIMAB; CXCR4 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LEUKOCYTE; LYMPHOCYTE HOMING; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MONOCLONAL B LYMPHOCYTE; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; WALDENSTROEM MACROGLOBULINEMIA; B CELL LYMPHOMA; BIOPSY; BIOSYNTHESIS; BLOOD; BONE MARROW EXAMINATION; METHODOLOGY; NONHODGKIN LYMPHOMA; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MATCHED-PAIR ANALYSIS; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES;

EID: 78549251425     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-644     Document Type: Article

References (11)

1. Yan Y, Chan WC, Weisenburger DD, Anderson JR, Bast MA, Vose JM, Bierman PJ, Armitage JO. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. Journal of Clinical Oncology 1995, 13:1336-1342.
2. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V. Revised response criteria for malignant lymphoma. Journal of Clinical Oncology 2007, 25:579-586. 10.1200/JCO.2006.09.2403, 17242396.
3. Laurence AD. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. British Journal of Haematology 2006, 132:255-267. 10.1111/j.1365-2141.2005.05841.x, 16409290.
4. Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Martinelli G. CXCR4-neutralization, a novel therapeutic approach for non-Hodgkin lymphoma. Cancer Research 2002, 62:3106-3112.
5. Harris NH, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfileld CD. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. Journal of Clinical Oncology 1999, 17:3835-3849.
6. Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 2002, 16:1460-1469. 10.1038/sj.leu.2402584, 12145686.
7. Hanson CA, Kurtin PJ, Jerry A, Katzmann JA, Hoyer JD, Li CY, Hodnefield JM, Meyers CH, Habermann TM, Witzig TE. Immunophenotypic Analysis of Peripheral Blood and Bone Marrow in the Staging of B-Cell Malignant Lymphoma. Blood 1999, 94:3889-3896.
8. Rawstron AC, Villamor N, Ritgen M, Böttcher S, Ghia P, Zehnder JL, Lozanski G, Colomer D, Moreno C, Geuna M, Evans PA, Natkunam Y, Coltre SE, Avery ED, Rassenti LZ, Kipps TJ, Caligaris-Cappio F, Kneba M, Byrd JC, Hallek MJ, Montserrat E, Hillmen P. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia 2007, 21:956-964.
9. Perea G, Altes A, Bellido M, Aventin A, Bordes R, Ayats R, Remacha AF, Espinosa I, Briones J, Sierra J, Nomdedeu JF. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas. Histopathology 2004, 45:268-274. 10.1111/j.1365-2559.2004.01937.x, 15330805.
10. Ngo HT, Leleu X, Lee J, Jia X, Melhem M, Runnels J, Moreau AS, Burwick N, Azab AK, Roccaro A, Azab F, Sacco A, Farag M, Sackstein R, Ghobrial IM. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood 2008, 112:150-158. 10.1182/blood-2007-12-129395, 2435685, 18448868.
11. Gronich N, Radnay J, Shapiro H, Manor Y, Lahav M, Lishner M. Clinical outcome of low-grade NHL patients with bone marrow involvement. European Journal of Clinical Investigation 2007, 37:05-309.